Read + Share
Amedeo Smart
Independent Medical Education
Parshina E, Zulkarnaev A, Tolkach A, Ivanov A, et al. Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study. Ren Fail 2022;44:392-398.PMID: 35220855
Email
LinkedIn
Facebook
Twitter
Privacy Policy